Zobrazeno 1 - 10
of 74
pro vyhledávání: '"J. Pikiel"'
Autor:
A. Oaknin, B. Pothuri, L. Gilbert, R. Sabatier, J. Brown, S. Ghamande, C. Mathews, D. O'Malley, V. Boni, A. Gravina, S. Banerjee, R. Miller, J. Pikiel, M.R. Mirza, T. Duan, X. Han, S. Zildjian, N. Dewal, null J.Veneris, A.V. Tinker
Publikováno v:
Annals of Oncology. 33:S797-S798
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd783a2dcf7fca10cded370beaecf225
https://doi.org/10.1016/j.annonc.2022.07.675
https://doi.org/10.1016/j.annonc.2022.07.675
Autor:
T. André, D. Berton-Rigaud, G. Curigliano, R. Sabatier, A.V. Tinker, A. Oaknin, F.G.M. De Braud, S. Ellard, H-T. Arkenau, J.M. Trigo Perez, J. Brown, A. Jewell, J. Pikiel, M.R. Mirza, T. Duan, G. Antony, S. Zildjian, E. Zografos, J. Veneris, S. Banerjee
Publikováno v:
Annals of Oncology. 33:S799-S800
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86acf5c39cd0fa930abb97b7be605113
https://doi.org/10.1016/j.annonc.2022.07.677
https://doi.org/10.1016/j.annonc.2022.07.677
Autor:
A.V. Tinker, B. Pothuri, L. Gilbert, R. Sabatier, J. Brown, S. Ghamande, C. Mathews, D. O'Malley, V. Boni, A. Gravina, S. Banerjee, R. Miller, J. Pikiel, M.R. Mirza, T. Duan, G. Antony, S. Zildjian, E. Zografos, J. Veneris, A. Oaknin
Publikováno v:
Annals of Oncology. 33:S798-S799
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa3b0b860ad3ebc373385bbd1cc521a7
https://doi.org/10.1016/j.annonc.2022.07.676
https://doi.org/10.1016/j.annonc.2022.07.676
Autor:
Kedan Lin, B Mackowiak-Matejczyk, Erika Hamilton, Joyce F. Liu, Kathleen N. Moore, Daniel J. Maslyar, Amit M. Oza, Michael J. Birrer, Lemahieu, Peter Trask, YounJeong Choi, Eva Schuth, Susana Banerjee, Jurjees Hasan, Jim Marsters, Yulei Wang, Eric W. Humke, Alexandra Leary, J Pikiel, I.L. Ray-Coquard, Anjali Vaze
Publikováno v:
Annals of Oncology. 29:917-923
Background: Lifastuzumab vedotin (LIFA) is a humanized anti-NaPi2b monoclonal antibody conjugated to a potent antimitotic agent, monomethyl auristatin E, which inhibits cell division by blocking the polymerization of tubulin. This study is the first
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8519f73d32b5b9c05711fed482cb5035
https://doi.org/10.1093/annonc/mdy023
https://doi.org/10.1093/annonc/mdy023
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J. Bosch-Barrera, J. Subramanian, J. Pikiel, Ellie Im, Rebecca Kristeleit, Desamparados Roda, Victor Moreno, W. Guo, H. Danaee
Publikováno v:
Annals of Oncology. 31:S886-S887
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac5031967ef5bcdd3ee62d29f7a83225
https://doi.org/10.1016/j.annonc.2020.08.1713
https://doi.org/10.1016/j.annonc.2020.08.1713
Autor:
Igor Bondarenko, J. Pikiel, M. Li, Melissa Lynne Johnson, A. Kurochkin, Ira Jacobs, Konstantin Penkov, Ruifeng Li, H.K. Ahn, B.C. Chul Cho, M. Bowers
Publikováno v:
Annals of Oncology. 31:S721
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c1e7f70b6f313b5a0cbb6ee5736abbd
https://doi.org/10.1016/j.annonc.2020.08.1175
https://doi.org/10.1016/j.annonc.2020.08.1175
Autor:
Y. Kulyaba, A. Kurochkin, K. Penkov, Alison Forgie, Jasmine Davda, Byoung Chul Cho, J. Pikiel, Hee Kyung Ahn, Igor Bondarenko, S. Odintsova, Ira Jacobs, Melissa Lynne Johnson, M. Korozan, Farhad Kazazi, Jeffrey Chou, Xiao Wang, Ruifeng Li
Publikováno v:
Annals of Oncology. 30:v518-v519
Background The first-in-human, ongoing phase I study of PF-06801591, a humanized IgG4 antibody to programmed cell death 1 (PD-1) receptor, consisted of a Part 1 dose escalation and Part 2 dose expansion. In Part 1, PF-06801591 was administered intrav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0d9d32be0aa5378dbed56a22be0d990
https://doi.org/10.1093/annonc/mdz253.100
https://doi.org/10.1093/annonc/mdz253.100
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
J Pikiel, M de Silvio, Elżbieta Starosławska, Etienne Brain, P Potemski, FJ Sapunar, Boguslawa Karaszewska, Christos Papadimitriou, Wolfgang Janni, C Caglevic, K Briggs, Christoph Salat, T Sarosiek
Publikováno v:
Cancer Research. 72:P5-18
Background: Lapatinib (L), a dual kinase inhibitor of epidermal growth factor receptor and ErbB2, is effective in the treatment of ErbB2+ MBC in combination with capecitabine (C) following progression after trastuzumab, anthracyclines, and taxanes. V
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7810f0b64d6911b019e631baa794a7e3
https://doi.org/10.1158/0008-5472.sabcs12-p5-18-21
https://doi.org/10.1158/0008-5472.sabcs12-p5-18-21